|
Biosite Determines that Offer from Inverness Constitutes a 'Superior Proposal' (ThomasNet)
Beckman Coulter Has Right to Match Offer Under Merger Agreement SAN DIEGO, April 25 / -- Biosite Incorporated (NASDAQ:BSTE) today announced that it has received a binding offer from Inverness Medical Innovations, Inc. (AMEX:IMA) to enter into a merger transaction pursuant to which Inverness would acquire 100% of the outstanding shares of common stock of Biosite, other than Biosite shares already ...
(May 4, 2007)
Biosite Announces Regulatory Clearance in Germany of Beckman Coulter Tender Offer (ThomasNet)
SAN DIEGO, April 24 / -- Biosite Incorporated (NASDAQ:BSTE) today announced that Beckman Coulter, Inc. (NYSE:BEC) has obtained clearance from the German Federal Cartel Office (the Bundeskartellamt) in connection with its proposed acquisition of Biosite pursuant to the tender offer described below. The tender offer is conditioned upon at least a majority of the outstanding Biosite shares, ...
(May 4, 2007)
Study to probe how healthy younger adults make use of genetic tests (EurekAlert!)
BETHESDA, Md., May 3, 2007—The National Human Genome Research Institute (NHGRI) and the National Cancer Institute (NCI), parts of the National Institutes of Health (NIH), have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions.
(May 4, 2007)
New Report Examines Strategies for Exploiting the Power of Genomics to Inform Studies in Immunology (RedNova)
Research and Markets (http://www.researchandmarkets has announced the addition of Decoding the Genomic Control of Immune Reactions: Novartis Foundation Symposium, No 281 to their offering.
(May 4, 2007)
Aptamer biosensors: an alternative to immunosensors (Medical Device Link)
Research stemming from the Human Genome Project has increased the demand for and applications of DNA sensors. Several commercial platforms are now available, including those of Affymetrix (Santa Clara, CA) and Illumina (San Diego).
(May 4, 2007)
TriMark Publications Announces Release of Its Clinical Laboratory Testing Reports (PR Web)
TriMark Publications (http://www.trimarkpublication a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Clinical Laboratory Testing reports Volumes 1 and 2. (PRWeb May 4, 2007) Post Comment:Trackback URL: http://www.prweb.com/pingpr.ph
(May 4, 2007)
TriMark Publications Announces Release of Its Clinical Laboratory Testing Reports (PRWeb via Yahoo! News)
TriMark Publications (http://www.trimarkpublication a global leader in the biotechnology, healthcare and life sciences publishing, announces the release of its Clinical Laboratory Testing reports Volumes 1 and 2.
(May 4, 2007)
Study To Probe How Healthy Younger Adults Make Use Of Genetic Tests (Science Daily)
The National Human Genome Research Institute and the National Cancer Institute, parts of the National Institutes of Health, have teamed with Group Health Cooperative in Seattle and Henry Ford Health System in Detroit to launch a study to investigate the interest level of healthy, young adults in receiving genetic testing for eight common conditions. The study is called the Multiplex Initiative.
(May 4, 2007)
Florida Atlantic University and Torrey Pines Institute for Molecular Studies Enter into Agreement for Cancer Research (U.S. Newswire via Yahoo! News)
Florida Atlantic University and Torrey Pines Institute for Molecular Studies (TPIMS) have signed an agreement to use compounds from TPIMS to enable faculty and students from the Charles E. Schmidt College of Science to work to identify anti-cancer drugs and therapies.
(May 4, 2007)
Sleep Deprivation Can Threaten Competent Decision-Making, Judicial Sleepiness Regarded With High Level Of Negativity (Medical News Today)
Gambling is a risky activity that can potentially result in the loss of a significant amount of money. Sleep deprivation can adversely affect a person's decision-making at a gambling table by elevating the expectation of gains and making light of one's losses following risky decisions. [click link for full article]
(May 4, 2007)
Ashley Bolden (St Louis Commerce Magazine)
entered the University of Missouri-Columbia (MIZZOU) planning a career as a medical doctor. But four years of undergraduate research—washing lab dishes her freshman year and working up to a nationally recognized project on the effects of estrogen on rats—opened her eyes to new possibilities.
(May 4, 2007)
New virus test technology experimented (People's Daily)
A new virus test technology featuring DNA test has entered the phase of clinical experiment, said a scientist in east China.
(May 5, 2007)
Biotech Sector To Get Further Boost With Signing Of MOUs (Bernama)
BOSTON, May 5 (Bernama) -- Malaysia's biotechnology endeavour is set to get a further boost with the memorandums of understanding (MOUs) to be sealed at the BIO International Convention 2007 (BIO 2007) next week.
(May 5, 2007)
Universities Can Help Speed Up Biotech Development In M'sia (Bernama)
BOSTON (US), May 5 (Bernama) -- Local universities can help speed up the biotechnology sector's development, especially through research and development activities related to the industry individually or on a joint venture basis, Science, Technology and Innovation Minister Datuk Seri Dr Jamaludin Jarjis said today.
(May 5, 2007)
Rare 'Gene-For-Gene' Interaction That Helps Bacteria Kill Their Host, Discovered By Scientists (Medical News Today)
Scientists have discovered that a cousin of the plague bacterium uses a single gene to out-fox insect immune defences and kill its host.In research published in the journal Proceedings of the National Academy of Science, scientists have found that Photorhabdus bacteria produce an antibiotic which inhibits the work of an enzyme that insects' immune systems use to defend themselves from attack. ...
(May 5, 2007)
Outlook: School's In (Contract Magazine)
Education historically offers strong opportunities for architects, designers, and builders. New schools accommodate population growth and renovations repair and upgrade aging facilities. These needs haven't lessened.
(May 6, 2007)
Scientists coming to region to join cancer fight (Pittsburgh Tribune-Review)
State-of-the art labs, monetary support and a large patient population make the area attractive.
(May 6, 2007)
Pittsburgh key in fight against cancer (Pittsburgh Tribune-Review)
Men and women in Western Pennsylvania are fighting to save the half-million Americans who will die from cancer each year.
(May 6, 2007)
Designer crops, better health — genetic changes aren't top priority (Salisbury Post)
KANNAPOLIS — Not only will scientists at the N.C. Research Campus create designer diets, they will breed and grow designer crops intended to boost nutrition, improve taste and fight disease and famine.
(May 6, 2007)
What is Biotechnology? (Boston Globe)
What is biotechnology? In a strict sense, it means altering live cells and putting them to work. By splicing new genes into the DNA of bacteria or other organisms, scientists can program them to make drugs. They can also introduce new genes into crops and create microbes that produce industrial chemicals.
(May 6, 2007)
Echinacea And St John's Wort Research At Iowa State Renewed By $4.4 Million NIH Grant (Medical News Today)
A five-year-old research center dedicated to understanding and improving Echinacea and Hypericum perforatum (St. John's wort) has received $4.4 million in continuation funding from the National Institutes of Health. The renewal is for three years.The Iowa Center for Research on Botanical Dietary Supplements at Iowa State University was created in 2002 by the NIH Office of Dietary Supplements. ...
(May 6, 2007)
All work and no play? Hardly (Boston Globe)
Many biotech giants have their headquarters in or around Cambridge's Kendall Square, just a short distance from the Massachusetts Institute of Technology. The square is still mostly a place to do business, but the high concentration of companies is also starting to spawn its own culture, with bars and lunch spots in the area catering to the biotech set. Here's ...
(May 6, 2007)
The future of biotech: Experts look at what's next (Boston Globe)
THE BIOTECHNOLOGY GURU Robert S. Langer
(May 6, 2007)
Springer Launches New Journal In Ophthalmology (Medical News Today)
Springer will launch a new multidisciplinary journal in ophthalmic research, the Journal of Ocular Biology, Diseases, and Informatics, in March 2008. The journal will be published under the Humana Press imprint. The publication will cover all aspects of research on ocular biology, including blinding diseases which affect more than 20 million people in the United States alone. [click link for full ...
(May 6, 2007)
The trickle of good jobs has begun (The Buffalo News)
Fred Zeigler is among the first. Give us more of him, and things will change. New technology will replace old industry. Jobs will come instead of leave. Company names like Medcotek and Pharmideas will roll off of our lips the way Trico and Bethlehem Steel once did.
(May 6, 2007)
All work and no play? Hardly (Boston Globe)
Many biotech giants have their headquarters in or around Cambridge's Kendall Square, just a short distance from the Massachusetts Institute of Technology. The square is still mostly a place to do business, but the high concentration of companies is also starting to spawn its own culture, with bars and lunch spots in the area catering to the biotech set. Here's ...
(May 6, 2007)
Novel antitumour agent (Pharmalicencing)
Small peptide that has shown encoraging anticancer activity in vitro and in vivo
(May 6, 2007)
Wallaby Milk Compounds Effective Against Antibody Resistant "Superbugs" (Market Wire via Yahoo! Finance)
Scientists from Victoria, Australia, have begun pre-clinical trials of a compound found in wallaby milk designed to fight antibiotic resistant 'superbugs.' "This is an important step towards the development of the antimicrobial compound AGG01 which may prove vital in the war against increasingly resistant human and animal diseases," announced Victorian Premier Steve Bracks at Bio 2007 in Boston.
(May 6, 2007)
Wallaby Milk Compounds Effective Against Antibody Resistant "Superbugs" (RedNova)
Scientists from Victoria, Australia, have begun
(May 6, 2007)
Wallaby Milk Compounds Effective Against Antibody Resistant "Superbugs" (SYS-CON Media)
Scientists fromVictoria, Australia, have begun pre-clinical trials of a compound found inwallaby milk designed to fight antibiotic resistant 'superbugs.' 'This isan important step towards the development of the antimicrobial compoundAGG01 which may prove vital in the war against increasingly resistant humanand animal diseases,' announced Victorian Premier Steve Bracks at Bio 2007in Boston.
(May 6, 2007)
Single gene is responsible for most cool temperature sensation (News-Medical-Net)
The discovery, reported in the May 3 issue of the journal Neuron, might one day lead to the development of drugs that induce cold sensation as an analgesic, or block it to prevent certain forms of chronic pain associated with cold sensation.
(May 7, 2007)
There may be a real code to chromosomal organization (News-Medical-Net)
The identification of a cluster of essential genes on mouse chromosome 11 as well as similar clusters on the chromosomes of other organisms , including humans , buttresses the argument that there may be rules as to how genes are structured or laid out on chromosomes, said the Baylor College of Medicine senior author of a report that appears online in the Public Library of Science Genetics, an ...
(May 7, 2007)
Lab-on-a-chip speeds proteomics research (News-Medical-Net)
In recent years, the science of biology has been dominated by genomics, the study of genes and their functions.
(May 7, 2007)
Renewal of Echinacea and St John's Wort research (News-Medical-Net)
A five-year-old research center dedicated to understanding and improving Echinacea and Hypericum perforatum (St. John's wort) has received $4.4 million in continuation funding from the National Institutes of Health. The renewal is for three years.
(May 7, 2007)
Kiwi help in gene studies (Stuff)
Kiwi biologists will be able to use New Zealand-made software and high-speed grid computing to solve genetics puzzles starting in 2009.
(May 7, 2007)
Genomes for the Masses (Technology Review)
The proliferation and plummeting cost of DNA sequencing heralds the year of the personal genome.
(May 7, 2007)
Leading Scientist And Innovator To Receive Honorary Degree (Medical News Today)
Craig Venter, an internationally known scientist who is responsible for developing high volume genome sequencing, will receive an honorary doctorate from Arizona State University on May 10 at a 9:30 a.m. commencement ceremony.An entrepreneur and maverick in both science and business, Venter was named Scientist of the Year by TIME magazine in 2000. [click link for full article]
(May 7, 2007)
Starpharma's DNT Priostar(TM) Dendrimers Significantly Improve Properties of Marketed Fluorescent Reagents (PR Newswire via Yahoo! Finance)
Starpharma , through its US subsidiary company Dendritic Nanotechnologies Inc , has found that DNT's Priostar dendrimer technology can be used to amplify the signal and increase the duration of the signal of existing products in the multi-billion dollar fluorescent reagents market.
(May 7, 2007)
Embracing biotechnology (Boston Globe)
THE REAL Massachusetts miracle is that we have thrived for nearly four centuries in a place that lacks almost every natural advantage except cranberries. We have achieved this by reinventing ourselves.
(May 7, 2007)
Accept GM food, expert says (Daily Telegraph)
AUSTRALIANS will have to accept genetically modified (GM) food if the agriculture industry is to continue in an era of climate change, a plant genetics expert says.
(May 7, 2007)
Fostering innovation in drug discovery (BizJournals)
The two critical components of today's research-driven organizations are people and high tech laboratories. Most research facilities are organized around the premise that putting together great scientists and good technologies would do the trick -- and reap a rich pipeline of new drugs.
(May 7, 2007)
Bay State digs deep, grows up since BIO 2000 (BizJournals)
When BIO last held its conference in Boston seven years ago, the human genome hadn't been fully sequenced, biotech stock prices were soaring, bioinformatics was brand-new, and global pharmaceutical competition hadn't heated up yet.
(May 7, 2007)
Future doctors could monitor health through music of the patients' genes (Boston Globe)
There's musical gene expression (see: Hank Williams the first, second, and third) and musical Gene expression (see: Gene Simmons with his tongue out). And then there's the Musical Gene Expression project at Harvard Medical School, which envisions a future where doctors will be able to tune in to the internal music of their patients.
(May 7, 2007)
Starpharma's DNT Priostar(TM) Dendrimers Significantly Improve Properties of Marketed Fluorescent Reagents (RedNova)
MELBOURNE, Australia, May 7 /PRNewswire-FirstC
(May 7, 2007)
Takara Bio Grants Transgenomic License for LA-PCR Technology (Japan Corporate News)
Tokyo, Japan, May 7, 2007 - (JCN Newswire) - Takara Bio Inc. (TSE: 4974) today announced that it has granted Transgenomic, Inc. a worldwide non-exclusive license to make, use and sell LA-PCR related products.
(May 7, 2007)
Cartesian Gridspeed of New Zealand Launches Revolutionary Genomics Sequencing Software in US Market (Business Wire via Yahoo! Finance)
AUCKLAND, New Zealand----Cartesian Gridspeed, a New Zealand bioinformatics software developer, will officially launch its SLIM Search product to the US market at the BIO 2007 Convention today in Boston.
(May 7, 2007)
Intransa Delivers Industry's First Scalable 10 GbE Enterprise IP SAN (Business Wire via Yahoo! Finance)
SAN JOSE, Calif.----Intransa, the global leader of scalable, network-centric IP storage solutions, today introduced the Intransa StorStac PCU100, the storage industry's first scalable 10 GbE Enterprise IP SAN.
(May 7, 2007)
Invitrogen and FAST Create Premiere Life Science Search Capability (Business Wire via Yahoo! Finance)
CARLSBAD, Calif. & OSLO, Norway & NEEDHAM, Mass.----Fast Search & Transfer (FAST), a leading developer of search technologies and Invitrogen Corporation , an industry leading provider of products and services for disease research and drug discovery, today announced that Invitrogen has implemented FAST ESP to enhance the scientific search and navigation capabilities within their award winning ...
(May 7, 2007)
Avesthagen gets Rs 225 mn share capital investment from NYLIM India fund (PharmaBiz)
Avestha Gengraine Technologies Pvt. Ltd., India's leading systems biology innovation company, has announced an Rs 225 million investment in share capital by New York Life Investment Management India Fund (FVCI II), LLC (NYLIM India Fund) through equity shares for a minority stake.
(May 7, 2007)
Intransa Delivers Industry's First Scalable 10 GbE Enterprise IP SAN (Broadcast Newsroom)
SAN JOSE, Calif., BUSINESS WIRE -- Intransa, the global leader of scalable, network-centric IP storage solutions, today introduced the Intransa StorStac PCU100, the storage industry's first scalable 10 GbE Enterprise IP SAN. The StorStac Storage System PCU100 (Performance Controller Unit 100) joins Intransa's StorStac System family and is specifically optimized for content rich server and ...
(May 7, 2007)
|
